• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The Canadian journal of hospital pharmacy. >Coping Strategies Used by Patients Infected with Hepatitis C Virus Who Are Facing Medication Costs
【24h】

Coping Strategies Used by Patients Infected with Hepatitis C Virus Who Are Facing Medication Costs

机译：面对药费上涨的丙型肝炎病毒感染患者的应对策略

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Background: The prevalence of infection with hepatitis C virus (HCV) is increasing worldwide. Antiviral therapy, prescription and nonprescrip-tion medications, and nondrug therapies to treat HCV infection and to manage associated adverse effects are costly. Objective: To determine whether individuals infected with HCV attending a hepatology clinic were negatively affected by the costs of prescription medications, and if so, to determine coping strategies they adopted. Methods: Patients infected with HCV attending Hepatology Services, a clinic within the Queen Elizabeth II Health Sciences Centre in Halifax, Nova Scotia, were interviewed as part of an exploratory study (April 2 to July 8, 2008). The interview was based on a validated survey adapted for Nova Scotia. Information collected included demographic characteristics; types of prescription, nonprescription, and complementary medications used by patients; and strategies patients adopted to pay their medication costs. Results: Fifty patients (age 33-64 years) participated in the interviewer-administered survey, including 35 (70%) men and 19 people (38%) with household income less than Dollars 30 000. Frequendy used medications were antidepressants (19 patients [38%]), antihypertensive agents (12 [24%]), anxiolytics (10 [20%]), and nonsteroidal anti-inflammatory drugs (10 [20%]). More than half (29 [58%]) were concerned about having sufficient money to pay for their medications. Coping strategies adopted in response to costs of prescription medications were either self-initiated or undertaken in consultation with physicians and/or other health care professionals. Sixteen (32%) of the respondents expressed the belief that physicians usually do not consider patients' concerns about affordability when prescribing medications. Seven (14%) indicated they would seek help from a pharmacist to buy low-cost substitutes for their medications. Conclusion: This study highlighted a range of coping strategies adopted by patients inf...
机译：背景：全世界丙型肝炎病毒（HCV）感染的流行率正在上升。抗病毒疗法，处方药和非处方药以及用于治疗HCV感染和管理相关不良反应的非药物疗法的成本很高。目的：确定在肝病门诊就诊的HCV感染者是否受到处方药费用的负面影响，如果是，则确定他们采用的应对策略。方法：作为探索性研究的一部分，采访了在新斯科舍省哈利法克斯市伊丽莎白女王二世健康科学中心的肝病服务中心就诊的HCV感染患者，作为一项探索性研究的一部分（2008年4月2日至7月8日）。采访基于经过验证的，适用于新斯科舍省的调查。收集的信息包括人口统计特征;患者使用的处方，非处方和补充药物类型;以及患者采取的支付药物费用的策略。结果：50名患者（年龄33-64岁）参加了由访调员管理的调查，包括35名（70％）男性和19人（38％），家庭收入低于3万美元。经常使用的药物是抗抑郁药（19例） [38％]），抗高血压药（12 [24％]），抗焦虑药（10 [20％]）和非甾体类抗炎药（10 [20％]）。超过一半（29 [58％]）担心是否有足够的钱来支付药物费用。响应处方药成本而采取的应对策略是自行发起的，或者是在与医生和/或其他医疗保健专业人员协商后采取的。十六（32％）的受访者表示相信，医生在开药时通常不会考虑患者对负担能力的担忧。七（14％）表示他们将寻求药剂师的帮助，以购买低成本的药物替代品。结论：本研究强调了患者感染后采取的一系列应对策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号